Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
12 août 2021 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Company focused on gaining regulatory clarity for late-stage lenabasum program and advancing programs targeting the endocannabinoid system and integrins into the clinicAugmenting the pipeline through...